|
SLC30A6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.04269983945005E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.9222957387276E-11 |
| Normal-vs-Stage2 |
6.704300E-03 |
| Normal-vs-Stage3 |
3.670100E-02 |
| Normal-vs-Stage4 |
6.251700E-02 |
| Stage1-vs-Stage2 |
1.762610E-01 |
| Stage1-vs-Stage3 |
1.969810E-02 |
| Stage1-vs-Stage4 |
4.839600E-01 |
| Stage2-vs-Stage3 |
5.781800E-01 |
| Stage2-vs-Stage4 |
8.168000E-01 |
| Stage3-vs-Stage4 |
5.245400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.79470010969385E-10 |
| Normal-vs-AfricanAmerican |
1.32180000000925E-06 |
| Normal-vs-Asian |
1.271500E-02 |
| Caucasian-vs-AfricanAmerican |
8.101600E-01 |
| Caucasian-vs-Asian |
7.263000E-01 |
| AfricanAmerican-vs-Asian |
8.095400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.84037246448088E-12 |
| Normal-vs-Female |
4.210400E-02 |
| Male-vs-Female |
5.54799999999966E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.73030000000441E-05 |
| Normal-vs-Extreme_Weight |
1.95732319241415E-12 |
| Normal-vs-Obese |
1.155210E-04 |
| Normal-vs-Extreme_Obese |
6.13600000000103E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.774100E-02 |
| Normal_Weight-vs-Obese |
4.080600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.690000E-01 |
| Extreme_Weight-vs-Obese |
2.103800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.004200E-01 |
| Obese-vs-Extreme_Obese |
3.408400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.070800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.42160000052394E-07 |
| Normal-vs-Age(61-80Yrs) |
2.14249729069138E-11 |
| Normal-vs-Age(81-100Yrs) |
3.11570003130868E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.607000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.950300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.149900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.987700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.843200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.544200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.52389212360049E-12 |
| Normal-VS-Type2 PRCC |
4.82840000004536E-06 |
| Normal-VS-KIRP CIMP |
3.492000E-01 |
| Normal-VS-Unclassified PRCC |
1.234250E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.961770E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.216110E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.235100E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.358790E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.697200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.005900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8450999617059E-09 |
| Normal-vs-N1 |
4.400800E-01 |
| Normal-vs-N2 |
5.823800E-01 |
| N0-vs-N1 |
2.136200E-02 |
| N0-vs-N2 |
1.931580E-01 |
| N1-vs-N2 |
8.251600E-01 |
|
|
